Clin2
NCT04312880Possibly a fitEnrolling by invitation

Tranexamic acid during elective back surgery to reduce bleeding

Spine Surgery

Treatments studied

Part of Bones, joints & muscles, Pain clinical trials.

This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
65 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are having planned lower-back decompression surgery (lumbar laminectomy), with or without fusion
  • This is your main, first (primary) surgery for this hospital stay
  • You are an adult age 18 or older and can give informed consent
  • You do not have a history of blood clots in the lung or leg (DVT or PE)
  • Your blood tests before surgery are normal enough (PT/INR, aPTT, bleeding time) and your platelet count is 100 or higher
  • You are not pregnant, not in prison, and you are not allergic to tranexamic acid

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03553186Recruiting· Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This Phase 3 trial tests whether tranexamic acid can reduce bleeding during major spine fusion surgery for adults with scoliosis or spine degeneration. It may help lessen blood loss and the need for transfusions, while monitoring safety.

New York, New York
NCT07494032Not yet recruiting
Extended tranexamic acid after total knee replacement

This study tests whether taking tranexamic acid (a medication that helps blood clot) for a few days after knee replacement surgery can reduce bleeding and the need for blood transfusions. It may help patients recover with fewer complications.

New York, New York
NCT02314988Recruiting· Phase 2/Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.

San Francisco, California
NCT06427850Not yet recruiting
Tranexamic acid to reduce drainage after spinal fusion

This trial tests whether putting a medicine called tranexamic acid (which helps reduce bleeding) on the surgery site can lessen the fluid that drains after a common type of lower-back spinal fusion surgery. It's for people having a single-level minimally invasive fusion, and it might help you recover with less drainage and fewer complications.

NCT03849443Recruiting· Early Phase 1
Testing tranexamic acid to reduce bleeding after spine fusion

This trial studies whether a single dose or multiple doses of tranexamic acid (TXA) can reduce the chance you need a blood transfusion after spine fusion surgery. It also compares two different ways TXA may be given (by mouth and through a vein) to see which approach works best and is safe.

Chicago, Illinois
NCT06023212Recruiting· Phase 1/Phase 2
Tranexamic acid to prevent bleeding in spine surgery for lung cancer

This trial tests if a medicine called tranexamic acid can help reduce bleeding during surgery for lung cancer that has spread to the spine. It may be an option if you have a single tumor in your spine and are having separation surgery.

Hangzhou, Zhejiang

Hear when a new Spine Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.